ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently…